panel discussion | dr ullas batra | role of immunotherapy in lung cancer
Published 2 years ago • 134 plays • Length 54:21Download video MP4
Download video MP3
Similar videos
-
23:03
panel discussion: choosing right vad in lung cancer patients - dr. ullas batra
-
34:11
panel discussion | dr ullas batra | alesia 5 year update and optimal sequencing of tkis
-
31:49
panel discussion on mesothelioma | dr ullas batra
-
38:01
panel discussion | dr ullas batra | achieving dramatic insights into molecular oncology
-
35:44
panel discussion | dr ullas batra | hidden egfr threat role of amivantamab
-
24:47
dr ullas batra | panel discussion on the abstracts presented at wclc esmo
-
21:27
part 9-virtual tumor board: immune checkpoint inhibitors in the management of lung cancer- dr. ullas
-
8:50
c4-5,c5-6 slip disc & cervical pain treatment by ayurvedic neuro panchkarma, dr yogesh sharma, sikar
-
1:51:26
treatment panel: overview of brains tumors & treatment options
-
26:13
immunotherapies in lung cancer | 2022 evolution conference
-
1:38
unveiling the role of pathology in breast cancer: insights by dr. ann thomas
-
23:02
dr ullas batra | dissecting molecular differences between egfr exon 19 & 21 l858r mutations
-
34:18
molecular & pathology workshop - dr ullas batra - panel discussion - mtb 1
-
25:37
walk the frontline in alk nsclc - dr ullas batra
-
10:13
crsf 07th masterclass: choosing agents after 2nd & 3rd gen alk inhibitor resistance | dr ullas batra
-
17:37
braf - dr ullas batra - selection of 1st line targeted therapy for braf mutated nsclc
-
12:19
dr. ullas batra - unlocking the unmet need in met ex14 m nsclc
-
1:01:28
panel discussion | dr randeep singh | durvalumab in stage iii nsclc
-
23:31
part 9 - panel discussion metastatic lung cancer - role of targeted agents & immunotherapy- dr ullas
-
20:51
debate | dr ullas batra | egfr mutation 3gen tki vs 1gen tki combinations
-
17:14
dr ullas batra | piking the right strategy in hr ve her2 ve mbc
-
16:32
molecular & pathology workshop dr bharat jasani the role of pd l1 in lung cancer immunobiology immun